Online inquiry

IVTScrip™ mRNA-Human Go-alpha, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A))   (CAT#: GTTS-WK0321MR)

This product GTTS-WK0321MR is a type of mRNA having 120 nt poly(A) tail and modified with Cap 0 & N1-Methylpseudo-UTP. It ecodes the Go-alpha protein. This product can be used in -related researches.
Specifications
Product type mRNA
Modified bases N1-Methylpseudo-UTP
5' Cap Cap 0
Species Human
RefSeq NM_000516
Applications Gene therapy research
Format Powder
Quantity 100 µg
Purification oligo-dT affinity purification
Target Gene
Gene ID 2778
UniProt ID P63092
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ mRNA-Human Go-alpha, (Cap 0, N1-Methylpseudo-UTP, 120 nt-poly(A)) (GTTS-WK0321MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTTS-WK25634MR IVTScrip™ mRNA-Human ARL13B, (Cap 1, N1-Methylpseudo-UTP, 120 nt-poly(A)) mRNA ARL13B
GTTS-WK13406MR IVTScrip™ mRNA-Human ADAMTS7, (Cap 1, 5-Methoxy-UTP, 30 nt-poly(A)) mRNA ADAMTS7
GTTS-WK12544MR IVTScrip™ mRNA-Human ADGRG6, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 120 nt-poly(A)) mRNA ADGRG6
GTTS-WK3302MR IVTScrip™ mRNA-Human Synaptophysin, (Cap 0, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA Synaptophysin
GTTS-WK17699MR IVTScrip™ mRNA-Human APBB1IP, (Cap 0, 5-Methyl-CTP, 30 nt-poly(A)) mRNA APBB1IP
GTTS-WK14643MR IVTScrip™ mRNA-Human ANLN, (Cap 0, Pseudo-UTP, 120 nt-poly(A)) mRNA ANLN
GTTS-WK7067MR IVTScrip™ mRNA-Human TNC, (Cap 1, 5-Methyl-CTP & Pseudo-UTP, 30 nt-poly(A)) mRNA TNC
GTTS-WK27494MR IVTScrip™ mRNA-Human ASB11, (Cap 1, N1-Methylpseudo-UTP, 30 nt-poly(A)) mRNA ASB11
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
×

Webinar Register

Simone Pinto Carneiro, Ph.D.

Group Leader, Ludwig-Maximilians-University of Munich

date-time 10 AM EDT | May 19, 2026

Register Now →